| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |